High‐dose chemotherapy with autologous stem cell support for first‐line treatment of aggressive non‐Hodgkin lymphoma: a systematic review and meta‐analysis based on individual patient data

高剂量化疗联合自体干细胞支持一线治疗侵袭性非霍奇金淋巴瘤:基于个体患者数据的系统评价和荟萃分析

阅读:2

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1. To examine the effect of high‐dose chemotherapy regimens with autologous stem cell transplantation versus conventional chemotherapy on overall survival and progression‐free survival in patients with aggressive non‐Hodgkin lymphoma. 2. To identify factors that modify the effect of HD‐ASCT on overall survival and progression‐free survival in patients with aggressive non‐Hodgkin lymphoma.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。